Sökning: WFRF:(Fukasawa Takashi)
> (2009) >
A novel polymorphis...
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.
-
Mukonzo, Jackson K (författare)
-
- Röshammar, Daniel, 1979 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi,Institute of Neuroscience and Physiology, Department of Pharmacology
-
Waako, Paul (författare)
-
visa fler...
-
Andersson, Maria (författare)
-
Fukasawa, Takashi (författare)
-
- Milani, Lili (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper
-
Svensson, Jan Olof (författare)
-
Ogwal-Okeng, Jasper (författare)
-
- Gustafsson, Lars L (författare)
- Karolinska Institutet
-
- Aklillu, Eleni (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2009-08-07
- 2009
- Engelska.
-
Ingår i: British journal of clinical pharmacology. - : Wiley. - 1365-2125 .- 0306-5251. ; 68:5, s. 690-9
- Relaterad länk:
-
https://bpspubs.onli...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- AIMS: Efavirenz exhibits pharmacokinetic variability causing varied clinical response. The aim was to develop an integrated population pharmacokinetic/pharmacogenetic model and investigate the impact of genetic variations, sex, demographic and biochemical variables on single-dose efavirenz pharmacokinetics among Ugandan subjects, using NONMEM. METHODS: Efavirenz plasma concentrations (n = 402) from 121 healthy subjects were quantified by high-performance liquid chromatography. Subjects were genotyped for 30 single nucleotide polymorphisms (SNPs), of which six were novel SNPs in CYP2B6, CYP3A5 and ABCB1. The efavirenz pharmacokinetics was described by a two-compartment model with zero- followed by first-order absorption. RESULTS: Apparent oral clearance (95% confidence interval) was 4 l h l(-1) (3.5, 4.5) in extensive metabolizers. In the final model, incorporating multiple covariates, statistical significance was found only for CYP2B6*6 and CYP2B6*11 on apparent oral clearance as well as ABCB1 (rs3842) on the relative bioavailability. Subjects homozygous for CYP2B6*6 (G516T, A785G) and *11 displayed 21 and 20% lower apparent oral clearance, respectively. Efavirenz relative bioavailability was 26% higher in subjects homozygous for ABCB1 (rs3842). The apparent peripheral volume of distribution was twofold higher in women compared with men. CONCLUSIONS: The model identified the four factors CYP2B6*6, CYP2B6*11, a novel variant allele in ABCB1 (rs3842) and sex as major predictors of efavirenz plasma exposure in a healthy Ugandan population after single-dose administration. Use of mixed-effects modelling allowed the analysis and integration of multiple pharmacogenetic and demographic covariates in a pharmacokinetic population model.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Nyckelord
- Adult
- African Continental Ancestry Group
- genetics
- Anti-HIV Agents
- pharmacokinetics
- Benzoxazines
- pharmacokinetics
- Dose-Response Relationship
- Drug
- Female
- Humans
- Male
- Models
- Biological
- Models
- Genetic
- Polymorphism
- Genetic
- genetics
- Sex Factors
- Uganda
- Young Adult
- ABCB1
- PHARMACY
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Mukonzo, Jackson ...
-
Röshammar, Danie ...
-
Waako, Paul
-
Andersson, Maria
-
Fukasawa, Takash ...
-
Milani, Lili
-
visa fler...
-
Svensson, Jan Ol ...
-
Ogwal-Okeng, Jas ...
-
Gustafsson, Lars ...
-
Aklillu, Eleni
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Farmakologi och ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Farmaceutiska ve ...
- Artiklar i publikationen
-
British journal ...
- Av lärosätet
-
Göteborgs universitet
-
Karolinska Institutet
-
Uppsala universitet